Physician profile
Carter Doyle
NPI 1861255812
$4,180.73
in general payments reported to CMS, 2019-2025
18 companies · $2,599 in 2025
The $2,599 reported for 2025 was more than what 95% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,582 · 2025: $2,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,180.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $879.17 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $557.81 | 2024-2025 | Caplyta |
| Abbvie INC. | $514.35 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $406.19 | 2024-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Neurocrine Biosciences, INC. | $387.88 | 2024-2025 | Ingrezza |
| Alkermes, INC. | $301.18 | 2024-2025 | Aristada, Lybalvi |
| Lundbeck LLC | $290.21 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $282.91 | 2024-2025 | Spravato, Invega Sustenna |
| E.R. Squibb & Sons, L.L.C. | $175.98 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $137.58 | 2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $91.48 | 2024-2025 | Qelbree |
| Sage Therapeutics, LLC | $42.86 | 2025 | Zurzuvae |
| Corium, LLC | $25.49 | 2025 | Azstarys |
| Tempus Ai, INC | $23.84 | 2024 | |
| Collegium Pharmaceutical, INC. | $20.81 | 2025 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $20.60 | 2024 | Xelstrym |
| Ironshore Pharmaceuticals INC. | $14.42 | 2024 | |
| Tms Neurohealth Centers INC. | $7.97 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carter Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.